Jakob Triebel

1.1k total citations
50 papers, 770 citations indexed

About

Jakob Triebel is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Jakob Triebel has authored 50 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 14 papers in Cardiology and Cardiovascular Medicine and 11 papers in Obstetrics and Gynecology. Recurrent topics in Jakob Triebel's work include Blood Coagulation and Thrombosis Mechanisms (19 papers), Cardiovascular Issues in Pregnancy (12 papers) and Pregnancy and preeclampsia studies (11 papers). Jakob Triebel is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (19 papers), Cardiovascular Issues in Pregnancy (12 papers) and Pregnancy and preeclampsia studies (11 papers). Jakob Triebel collaborates with scholars based in Germany, Mexico and France. Jakob Triebel's co-authors include Carmen Clapp, Gonzalo Martı́nez de la Escalera, Thomas Bertsch, Yazmín Macotela, Bibiana Moreno-Carranza, Gundula Schulze‐Tanzil, Stéphanie Thebault, Norma Adán, Giuliano Ramadori and María G. Ledesma-Colunga and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jakob Triebel

47 papers receiving 757 citations

Peers

Jakob Triebel
Fatma Sılan Türkiye
M. A. Kelly United Kingdom
Kuk‐Wha Lee United States
Jacqueline M. Cale United States
M E Lee United States
Jakob Triebel
Citations per year, relative to Jakob Triebel Jakob Triebel (= 1×) peers Bibiana Moreno-Carranza

Countries citing papers authored by Jakob Triebel

Since Specialization
Citations

This map shows the geographic impact of Jakob Triebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakob Triebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakob Triebel more than expected).

Fields of papers citing papers by Jakob Triebel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jakob Triebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakob Triebel. The network helps show where Jakob Triebel may publish in the future.

Co-authorship network of co-authors of Jakob Triebel

This figure shows the co-authorship network connecting the top 25 collaborators of Jakob Triebel. A scholar is included among the top collaborators of Jakob Triebel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakob Triebel. Jakob Triebel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Siqueiros‐Márquez, Lourdes, Magdalena Zamora, Juan Pablo Robles, et al.. (2025). Vasoinhibin is Generated by the Renin-angiotensin System. Endocrinology. 166(3). 1 indexed citations
2.
Zamora, Magdalena, Lourdes Siqueiros‐Márquez, Jakob Triebel, et al.. (2025). Topical ophthalmic administration of the antiangiogenic peptide VIAN-c4551 protects against experimental diabetic macular edema. Scientific Reports. 15(1). 26767–26767.
3.
Zamora, Magdalena, Thomas Bertsch, Jakob Triebel, et al.. (2025). The antiangiogenic peptide VIAN-c4551 inhibits lung melanoma metastasis in mice by reducing pulmonary vascular permeability. PLoS ONE. 20(5). e0316983–e0316983.
4.
Robles, Juan Pablo, Magdalena Zamora, Thomas Bertsch, et al.. (2023). Vasoinhibin’s Apoptotic, Inflammatory, and Fibrinolytic Actions Are in a Motif Different From Its Antiangiogenic HGR Motif. Endocrinology. 165(2). 4 indexed citations
5.
Siqueiros‐Márquez, Lourdes, Ludivina Robles‐Osorio, Thomas Bertsch, et al.. (2022). Sulpiride‐induced hyperprolactinaemia increases retinal vasoinhibin and protects against diabetic retinopathy in rats. Journal of Neuroendocrinology. 34(4). e13091–e13091. 11 indexed citations
6.
Roth, Dominik von, Thomas Bertsch, Silke Schwarz, et al.. (2022). Complement Proteins C5/C5a, Cathepsin D and Prolactin in Chondrocytes: A Possible Crosstalk in the Pathogenesis of Osteoarthritis. Cells. 11(7). 1134–1134. 2 indexed citations
7.
Smetak, Manfred, Josef Birkmann, Thomas Bertsch, et al.. (2022). Immune activating and inhibiting effects of calcitriol on γδ T cells and NK cells. Immunobiology. 227(6). 152286–152286. 6 indexed citations
8.
Triebel, Jakob, Thomas Bertsch, & Carmen Clapp. (2022). Prolactin and vasoinhibin are endogenous players in diabetic retinopathy revisited. Frontiers in Endocrinology. 13. 994898–994898. 5 indexed citations
9.
Friedrich, Christin, Magdalena Zamora, Juan Pablo Robles, et al.. (2021). Plasmin generates vasoinhibin-like peptides by cleaving prolactin and placental lactogen. Molecular and Cellular Endocrinology. 538. 111471–111471. 10 indexed citations
10.
Zamora, Magdalena, Juan Pablo Robles, Manuel B. Aguilar, et al.. (2021). Thrombin Cleaves Prolactin Into a Potent 5.6-kDa Vasoinhibin: Implication for Tissue Repair. Endocrinology. 162(12). 12 indexed citations
11.
Escalera, Gonzalo Martı́nez de la, et al.. (2020). A Dysregulation of the Prolactin/Vasoinhibin Axis Appears to Contribute to Preeclampsia. Frontiers in Endocrinology. 10. 893–893. 12 indexed citations
12.
Triebel, Jakob, Juan Pablo Robles, Magdalena Zamora, et al.. (2019). Regulator of Angiogenesis and Vascular Function: A 2019 Update of the Vasoinhibin Nomenclature. Frontiers in Endocrinology. 10. 214–214. 8 indexed citations
13.
Triebel, Jakob, et al.. (2019). Analysing Point Mutations in Protein Cleavage Sites by Using Enzyme Specificity Matrices. Frontiers in Endocrinology. 10. 267–267. 2 indexed citations
14.
Robles, Juan Pablo, Magdalena Zamora, Ramón Garduño‐Juárez, et al.. (2018). Vasoinhibin comprises a three-helix bundle and its antiangiogenic domain is located within the first 79 residues. Scientific Reports. 8(1). 17111–17111. 13 indexed citations
15.
Triebel, Jakob, Gonzalo Martı́nez de la Escalera, Carmen Clapp, & Thomas Bertsch. (2017). Vasoinhibins May Contribute to Postpartum Depression. Frontiers in Psychiatry. 8. 167–167. 5 indexed citations
16.
Triebel, Jakob, Carmen Clapp, Gonzalo Martı́nez de la Escalera, & Thomas Bertsch. (2017). Remarks on the Prolactin Hypothesis of Peripartum Cardiomyopathy. Frontiers in Endocrinology. 8. 77–77. 9 indexed citations
17.
Triebel, Jakob, et al.. (2017). Human Prolactin Point Mutations and Their Projected Effect on Vasoinhibin Generation and Vasoinhibin-Related Diseases. Frontiers in Endocrinology. 8. 294–294. 6 indexed citations
18.
Zepeda‐Romero, Luz Consuelo, et al.. (2016). Higher prolactin and vasoinhibin serum levels associated with incidence and progression of retinopathy of prematurity. Pediatric Research. 81(3). 473–479. 20 indexed citations
19.
Clapp, Carmen, Stéphanie Thebault, Yazmín Macotela, et al.. (2014). Regulation of Blood Vessels by Prolactin and Vasoinhibins. Advances in experimental medicine and biology. 846. 83–95. 54 indexed citations
20.
Triebel, Jakob, Yazmín Macotela, Gonzalo Martı́nez de la Escalera, & Carmen Clapp. (2011). Prolactin and vasoinhibins: Endogenous players in diabetic retinopathy. IUBMB Life. 63(10). 806–810. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026